Page last updated: 2024-08-16

potassium chloride and rosiglitazone

potassium chloride has been researched along with rosiglitazone in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Althaym, A; Brunmair, B; Clara, R; Fürnsinn, C; Gnaiger, E; Gras, F; Nohl, H; Roden, M; Scharf, N; Staniek, K; Waldhäusl, W1
Ari, N; Aslamaci, S; Irat, AM; Karasu, C1
Abo-Warda, SM; El-Bassossy, HM; Fahmy, A1

Other Studies

3 other study(ies) available for potassium chloride and rosiglitazone

ArticleYear
Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?
    Diabetes, 2004, Volume: 53, Issue:4

    Topics: Animals; Electron Transport Complex I; Energy Metabolism; Hypoglycemic Agents; Male; Metformin; Mitochondria; Muscle, Skeletal; Oxygen Consumption; Pioglitazone; Potassium Chloride; Rats; Rats, Sprague-Dawley; Rosiglitazone; Rotenone; Thiazolidinediones

2004
Alteration of vascular reactivity in diabetic human mammary artery and the effects of thiazolidinediones.
    The Journal of pharmacy and pharmacology, 2006, Volume: 58, Issue:12

    Topics: Aged; Cromakalim; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelium, Vascular; Female; Glyburide; Humans; Hypoglycemic Agents; Male; Mammary Arteries; Middle Aged; Nitroprusside; Phenylephrine; Pioglitazone; Potassium Channel Blockers; Potassium Chloride; Rosiglitazone; Thiazolidinediones; Vasoconstriction

2006
Rosiglitazone, a peroxisome proliferator-activated receptor γ stimulant, abrogates diabetes-evoked hypertension by rectifying abnormalities in vascular reactivity.
    Clinical and experimental pharmacology & physiology, 2012, Volume: 39, Issue:8

    Topics: Animals; Blood Glucose; Blood Pressure; Blood Vessels; Calcium; Cholesterol; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Glycation End Products, Advanced; Hypertension; Hypoglycemic Agents; In Vitro Techniques; Male; Nitric Oxide; Potassium Chloride; PPAR gamma; Rats; Rosiglitazone; Thiazolidinediones; Triglycerides

2012